Elon Musk Signals Intel 14A Chips for Tesla’s Terafab AI Semiconductor Venture 
Elon Musk Faces French Probe Over X and Grok Amid Rising U.S.-EU Tensions 
Jeff Bezos Eyes $10 Billion Funding Round for AI Venture Project Prometheus 
SpaceX Eyes $60B Cursor Deal to Boost AI Power Ahead of IPO 
Nidec Stock Rises After Accounting Probe Report Eases Delisting Concerns 
Apple Stock Dips as Tim Cook Steps Down, John Ternus Named Next CEO 
Florida Investigates OpenAI and ChatGPT Over Alleged Role in FSU Shooting 
J.P. Morgan Downgrades Essity AB on Rising Costs and Weak Earnings Outlook 
Microsoft Commits $18 Billion to Expand AI and Cloud Infrastructure in Australia 
European Car Sales Surge in March as EV and Hybrid Demand Accelerates 
SK Hynix Reports Record Q1 Profit Surge Driven by AI Memory Chip Demand 
Amazon Expands AI Bet with Up to $25 Billion Investment in Anthropic 
China Food Delivery Stocks Dip as Regulators Crack Down on “Ghost Deliveries” 
John Ternus Signals Apple’s Future with Product-First AI Strategy 
Polymarket Seeks $400M Funding Round, Targets $15B Valuation Amid Prediction Market Boom 
Tesla Earnings Beat Expectations as EV Growth Holds Amid Robotics and AI Shift 
Chinese Robotics Stocks React as Humanoid Robot Marathon Sparks Competition Concerns 
BATON ROUGE, La., March 13, 2017 -- Amedisys, Inc. (NASDAQ:AMED) today announced that Paul B. Kusserow, President and Chief Executive Officer, will present at the 27th Annual Oppenheimer Healthcare Conference in New York City, NY on Tuesday, March 21, 2017.
The presentation will begin at 2:45 p.m. Eastern Time. To access a live webcast of the Amedisys presentation, please log on through our website at http://investors.amedisys.com.
About Amedisys
Amedisys, Inc. is a leading healthcare at home Company delivering personalized home health, hospice and personal care. Amedisys is focused on delivering the care that is best for our patients, whether that is home-based personal care; recovery and rehabilitation after an operation or injury; care focused on empowering them to manage a chronic disease; or hospice care at the end of life. More than 2,200 hospitals and 61,900 physicians nationwide have chosen Amedisys as a partner in post-acute care. Founded in 1982, headquartered in Baton Rouge, LA with an executive office in Nashville, TN, Amedisys is a publicly held company. With more than 16,000 employees, in 421 care centers in 34 states, Amedisys is dedicated to delivering the highest quality of care to the doorsteps of more than 340,000 patients in need every year. For more information about the Company, please visit: www.amedisys.com.
Contact: Amedisys, Inc. David Castille Managing Director, Finance 225.299.3665 [email protected]
